When.com Web Search

  1. Ads

    related to: why is bumetanide prescribed for children with cancer patients and medication

Search results

  1. Results From The WOW.Com Content Network
  2. Bumetanide - Wikipedia

    en.wikipedia.org/wiki/Bumetanide

    Bumetanide was patented in 1968 and came into medical use in 1972. [5] It is on the World Health Organization's List of Essential Medicines. [6] It is available as a generic medication. [4] In 2020, it was the 270th most commonly prescribed medication in the United States, with more than 1 million prescriptions. [7] [8]

  3. Pain management in children - Wikipedia

    en.wikipedia.org/wiki/Pain_management_in_children

    Cancer pain in children may be caused by the cancer itself or the side effects of treatment. Tumors can cause pain in two different ways: by the physical pressure they place on organs or by occluding normal bodily functions. Treatment such as surgery and injections can also lead to significant pain for the patient. [9]

  4. Cancer pain - Wikipedia

    en.wikipedia.org/wiki/Cancer_pain

    Worldwide, nearly 80% of people with cancer receive little or no pain medication. [4] Cancer pain in children and in people with intellectual disabilities is also reported as being under-treated. [5] Guidelines for the use of drugs in the management of cancer pain have been published by the World Health Organization (WHO) and others.

  5. Chemotherapy - Wikipedia

    en.wikipedia.org/wiki/Chemotherapy

    Nutritional problems are also frequently seen in cancer patients at diagnosis and through chemotherapy treatment. Research suggests that in children and young people undergoing cancer treatment, parenteral nutrition may help with this leading to weight gain and increased calorie and protein intake, when compared to enteral nutrition. [138]

  6. List of investigational autism and pervasive developmental ...

    en.wikipedia.org/wiki/List_of_investigational...

    Bumetanide oral liquid (S-95008) – sodium–potassium–chloride symporter/cotransporter inhibitor and indirect GABAergic inhibitor [3] [4] Cariprazine (Reagila, Symvenu, Vraylar; MP-214, RGH-188, WID-RGC20) – dopamine D 2 and D 3 receptor partial agonist, serotonin 5-HT 1A receptor partial agonist, serotonin 5-HT 2B receptor antagonist ...

  7. Aprepitant - Wikipedia

    en.wikipedia.org/wiki/Aprepitant

    Aprepitant, sold under the brand name Emend among others, is a medication used to prevent chemotherapy-induced nausea and vomiting and to prevent postoperative nausea and vomiting. [5] It may be used together with ondansetron and dexamethasone. [5] It is taken by mouth [5] or administered by intravenous injection. [3]